You searched for "floaters"

386 results found

Braille phones, glaucoma implants and screenshots

Basic phone for Braille readers (or kids and the elderly) We’ve previously covered the extensive features of smartphones that can help the sight impaired. It’s clear, however, that smartphones are not for everyone. One alternative is a custom made Braille...

Glaucoma UK’s campaign raises awareness of glaucoma through people’s unique glaucoma stories

Glaucoma UK is marking Glaucoma Awareness Week 2023, which will run from 26 June to 2 July 2023.

What's trending Jun/Jul 2020

Here in the UK, we’ve been in lockdown since 23 March 2020, with much of the rest of the world entering degrees of lockdown since February-March 2020. COVID-19 has dominated the headlines and social media, so without further ado, I...

Santa Claus comes to the RNIB

It’s nearly that time of year again when Santa Claus and his elves at the North Pole are busy getting ready to spread festive joy to all children.

In vivo confocal microscopy, principles and use in keratitis Part 1: Principles

In 1968 Maurice introduced the concept of high powered specular microscopy, it was in that very year that the first scanning confocal microscope was proposed. Marvin Minsky developed the first confocal microscope in 1955 named the ‘double focusing scanning microscope’....

Sight Scotland Veterans launch new bowling team

Sight Scotland Veterans has launched a new lawn bowling team which will now compete in the Vision Impairment Bowling Scotland League (VIBS) with matches taking place all over Scotland.

Anatomical and functional outcomes following switching from aflibercept to ranibizumab in NARMD

This is a six-month, prospective, single-arm study in the UK and Germany. A total of 100 patients were enrolled (one in the primary failure group, 99 in the suboptimal treatment response group), treated three-monthly intravitreal ranibizumab injections (0.5mg), and then...

PRN Ranibizumab verses continuous aflibercept in UK clinical practice

This was a multicentre (21 UK hospitals), national EMR study on treatment naïve nAMD eyes, undergoing predominantly as needed (PRN) Ranibizumab or continuous (fixed or treat and extend - (F/TE)) Aflibercept (Af). The primary outcome was change in vision at...

OCT angiography in PAMM secondary to CRVO

Paracentral acute middle maculopathy (PAMM) is a recently described manifestation presenting with hyperreflective bands within mid retina on spectral domain optical coherence tomography (SD OCT). The current view is that these findings are markers of ischaemia of deep retinal circulation....

Ranibizumab versus laser in diabetic macular oedema (LUCIDATE study)

The aim of this study was to compare the functional and structural effects of Ranibizumab versus macular laser treatment in patients with diabetic macular oedema. It was a single centre, prospective, randomised, single masked clinical trial spanning a 48 week...

An eye on novel anti-cancer agents: an evidence-based approach to external eye assessment

Novel anti-cancer therapies have led to significant advancement in cancer treatment, however, they can be associated with external eye complications. It is important to be mindful of such adverse effects during assessment of patients enrolled in clinical trials. Annually, approximately...

Overcoming sight impairment for the Race Across the World!

RNIB’s Tricia travels the world and takes her message that "sight loss doesn’t stop you doing anything" to BBC One.